TickerFactsScreenerDevelopers

BIOCRYST PHARMACEUTICALS INC (BCRX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$13.74M2010: -$34.36M2011: -$49.59M2012: -$33.89M2013: -$30.72M2014: -$45.77M2015: -$39.44M2016: -$48.61M2017: -$57.41M2018: -$94.22M2019: -$99.45M2020: -$174.76M2021: -$177.72M2022: -$148.44M2023: -$103.71M2024: -$2.54M2025: $340.99M$340.99M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$340.99M+13508.9%
2024-$2.54M+97.5%
2023-$103.71M+30.1%
2022-$148.44M+16.5%
2021-$177.72M-1.7%
2020-$174.76M-75.7%
2019-$99.45M-5.6%
2018-$94.22M-64.1%
2017-$57.41M-18.1%
2016-$48.61M-23.2%
2015-$39.44M+13.8%
2014-$45.77M-49.0%
2013-$30.72M+9.4%
2012-$33.89M+31.7%
2011-$49.59M-44.3%
2010-$34.36M-150.1%
2009-$13.74M—